Abstract
More and more patients with solid or hematological tumors are admitted to the Intensive Care Units. The improvement in the physiopathological understanding of this group of patients, as well as the increasingly better and more targeted treatment options for their underlying disease, has led to a significant increase in their survival over the past two decades. We are living in an era in which we are defining the standards that offer the best way to care for them: From the organization and running of ICUs, the definition of clear admission criteria from the available evidence, and the development of new admission policies that expand the classic dichotomous view of whether or not they are candidates for admission to ICUs to analyzing the best treatment for them, avoiding excessive treatment, and, above all, respecting their principle of autonomy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Soares M, Carusi P, Silva E, et al. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med. 2010;38(1):9–15.
Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilation support: impact of noninvasive mechanical support. Crit Care Med. 2001;29(3):519–25.
Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009;13(1):R15.
Puxty K, McLoone P, Quasim T, et al. Survival in solid cancer patients following intensive care unit admission. Intensive Care Med. 2014;40(10):1409–28.
Toffart AC, Pizarro C, Schwebel C, et al. Selection criteria for intensive care unit referral of lung cancer patients: a pilot study. Eur Respir J. 2015;45:491–500.
Soares M, Bozza FA, Azevedo CP, et al. Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol. 2016;34:3315–24.
Carmona-Bayonas A, Gordo F, Beato C, et al. Intensive care in cancer patients in the age of immunotherapy and molecular therapies: commitment of the SEOM-SEMICYUC. Med Intensiva. 2018;42:363.
Nates JL, Nunnally M, Kleinpell R, Blosser S, Goldner J, Birriel B, Fowler CS, Byrum D, Miles WS, Bailey H, Sprung CL. ICU admission, discharge, and triage guidelines: a framework to enhance clinical operations, development of institutional policies, and further research. Crit Care Med. 2016;44(8):1553–602.
Soubani O. Critical care prognosis and outcomes in patients with cancer. Clin Chest Med. 2017;38(2):333–353.
Pinsky MR, Brochard L, Kellum JA. Ten recent advances that could not have come about without applying physiology. Intensive Care Med. 2015. https://doi.org/10.1007/s00134-015-3746-9. Online print 25th March.
Azoulay E, Pene F, Darmon M, et al. Managing critically ill hematology patients: time to think differently. Blood Rev. 2015;29(6):359–67.
Sbrana A, Torchio M, Comolli G, et al. Use of procalcitonin in clinical oncology: a literature review. New Microbiol. 2016;39(3):174–80.
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2016;66: 271–89.
Teno JM, Gozalo PL, Bynum J, et al. Change in end-of-life care for Medicare beneficiaries: site of dead, place of care, and health care transitions in 2000, 2005 and 2009. JAMA. 2009;309(5):470–7.
Benoit DD, Soares M, Azoulay E. Has survival increased in cancer patients admitted to the ICU? We are not sure. Intensive Care Med. 2014;40(10):1576–9.
Soubani AO, Decruyenaere J. Improved outcome of critically ill patients with hematological malignancies: what is next? Intensive Care Med. 2014;40(9):1377–8.
Nasir SS, Muthiad M, Ryder K, et al. ICU deaths in patients with advanced cancer: reasonable criteria to decrease potentially inappropriate admissions and lack of benefit of advance planning discussions. Am J Hosp Palliat Med. 2017;34(2):173–179.
Suh GY, Ryu JA, Chung CR, et al. Effect of early intervention on long term outcomes of critically ill cancer patients admitted to ICUs. Crit Care Med. 2015;43(7):1439–48.
Azoulay E, Mokart D, Péne E, et al. Outcomes of critically ill patients with hematological malignances prospective multicenter data from France and Belgium. J Clin Oncol. 2013;31(22):2810–8.
de Monmollin E, Tandjaoui-Lambiotte Y, Legrand M, et al. Outcome in critically ill cancer patients with septic shock of pulmonary origin. Shock. 2013;39(3): 250–4.
Thiery G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol. 2005;23(19):4406–13.
Auclin E, Charles-Nelson A, Abbar B, et al. Outcomes in elderly patients admitted to the intensive care unit with solid tumors. Ann Intensive Care. 2017;7:26.
Bouteloup M, Perinel S, Bourmaud A, et al. Outcomes in adult critically ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH). Oncotarget. 2017;8(1):1860–70.
Al-Zubaidi N, Soubani AO. Predictors of mortality in patients with hematologic malignancies admitted to the ICU- a prospective observational study. Am J Respir Crit Care Med. 2016;193:A3657.
Soares M, Fontes F, Dantas J, et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care Med. 2004;8(4):R194–203.
Bayraktar UD, Shpall EJ, Liu P, et al. Hematopoietic cell transplantation specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol. 2013;31(33): 4207–14.
Cárdenas-Turanzas M, Ensor J, Wakefield C, et al. Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care. 2012;27(6):673–80.
Aygencel G, Turkoglu M, Turkoz Sucak G, et al. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care. 2014;29:618–26.
Prendergast TJ, Luce JM. Increasing incidence of withholding and withdrawal of life support from the critically ill. Am J Respir Crit Care Med. 1997;155(1): 15–20.
Kostakou E, Rovina N, Kyriakopoulou M, et al. Critically ill cancer patient in intensive care unit: issues that arise. J Crit Care. 2014;29:817–22.
Keating NL, Landrum MB, Rogers SO, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116(4):998–1006.
Afessa B, Azoulay E. Critical care of the hematopoietic stern cell transplant recipient. Crit Care Med. 2010; 26(1):133–50.
Mendoza V, Lee A, Mark PE. The hospital survival and prognostic factors of patients with solid tumors admitted to an ICU. Am J Hosp Palliat Care. 2008;25:240–3.
Soares M, Salluh JL, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med. 2005;33:520–6.
Maccariello E, Valente C, Nogueira L, et al. Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant. 2011;26:537–43.
Benoit DD, Vandewoude KH, Decruyenaere JM, et al. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the ICU for a life-threatening complication. Crit Care Med. 2003;31(1):104–12.
Shimabukuro-Vornhagen A, Boll B, Kochanek M, et al. Critical care of patients with cancer. CA Cancer J Clin. 2016;66:496–517.
Frat JP, Thile AW, Mercat A, et al. High flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2186–96.
Mokart D, Geay C, Chow-Chine L, et al. High flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med. 2015;41:2008–10.
de Almeida JP, Vincent JL, Galas FR, et al. Transfusion requirements in surgical oncology patients: a prospective randomized controlled trial. Anesthesiology. 2015; 122:29–38.
Azoulay E, Schellongowski P, Darmon M, et al. The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 2017;43:1366–82.
Lecuyer L, Chevret S, Guidet B, et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med. 2007;35(3): 808–14.
Azoulay E, Afessa B. The intensive care support of patients with malignance: do everything that can be done. Intensive Care Med. 2006;32:3–5.
Suhag V, Sunita BS, Sarin A, et al. Intensive care for cancer patients, an overview. Asian Australas J Anim. 2014;13:193–201.
Shrime MG, Ferket BS, Scott DJ, et al. Time-limited trials of intensive care for critically ill patients with cancer: how long is long enough? JAMA Oncol. 2016;2:76–83.
Hosein FS, Roberts DJ, Turin TC, et al. A meta-analysis to derive literature-based benchmarks for readmission and hospital mortality after patient discharge from intensive care. Crit Care. 2014;18(6):715.
Stelfox HT, Bastos J, Niven DJ, et al. Critical care transition programs and the risk of readmission or death after discharge from ICU. Intensive Care Med. 2016;42(3):401–10.
Staudinger T, Stoiser B, Mullner M, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28:1322–1328.
Wohlfarth P, Staudinger T, Sperr W, et al. Prognostic factors, long term survival, and outcome of cancer patients receiving chemotherapy. Ann Hematol. 2014;93:1629–1636.
Wohlfarth P, Beutel G, Lebiedz P, et al. Characteristics and outcome of patients after allogenic sterm cell transplantation treated with extracorporeal membrane oxygenation for acute respiratory distress syndrome. Crit care Med. 2017;45:e500–e507.
Mogal HD, Levine E, Fino N, et al. Routine Admission to Intensive Care Unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement. Ann Surg Oncol. 2015;23:1486–1495.
Song JU, Suh GY, Park HY, et al. Early intervention on the outcomes in critically ill cancer patients admitted to intensive care unit. Intensive Care Med. 2012;38(9):1505–13. https://doi.org/10.1007/s00134-012-2594-0
Soares M, Fontes F, Dantas J, et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care Med. 2004;8(4):R194–203.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Pujol Varela, I., del Portillo, I.P. (2020). Critical Care Admissions and Discharge Criteria in Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74588-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-74588-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74587-9
Online ISBN: 978-3-319-74588-6
eBook Packages: MedicineReference Module Medicine